Community preparedness for HIV vaccine trials in the Democratic Republic of Congo

Culture, Health and Sexuality

Volumn 8, Issue 6, 2006, Pages 529-544

  Olin, John ^a   Kokolamami, Jacques ^b   Lepira, Francois B ^c   Mwandagalirwa, Kashamuka ^d   Mupenda, Bavon ^e   Ndongala, Michel Lubaki ^f   Maman, Suzanne ^g   Bollinger, Robert ^a   Nachega, Jean ^d   Mokili, John ^h  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Programme National de Lutte Contra   (Congo)

^c Cliniques Universitaires de Kinshasa   (Congo)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF KINSHASA   (Congo)

^f MCGILL UNIVERSITY   (Canada)

^g IL   (United States)

^h LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Clinical trials; Community preparedness; HIV AIDS; Stigma; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; ATTITUDE; ATTITUDE TO AIDS; CLINICAL RESEARCH; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DATA COLLECTION METHOD; DEMOCRATIC REPUBLIC CONGO; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN FACTORS RESEARCH; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERVIEW; MALE; MOTIVATION; PATIENT PARTICIPATION; PRIORITY JOURNAL; RESEARCH SUBJECT; SEXUAL BEHAVIOR; STATISTICAL SIGNIFICANCE; UNIVERSITY STUDENT;

ADULT; AIDS VACCINES; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; CONGO; CULTURAL CHARACTERISTICS; DEMOCRATIC REPUBLIC OF THE CONGO; DISEASE OUTBREAKS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES;

EID: 33750018130     PISSN: 13691058     EISSN: 14645351     Source Type: Journal    
DOI: 10.1080/13691050600888434     Document Type: Article

References (18)

1. Albdelkader, B. (2002). In Capacity Building for Community Groups in Preparation for HIV Vaccine Processes in Africa, Highlights from Repport. AfriCASO Workshop: Nairobi.
2. Celentano, D. D. and Beyrer, C. and Natpratan, C. and Eiumtrakul, S. and Sussman, L. and Renzullo, P. O. and Khamboonruang, C. and Nelson, K. E. (1995) Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. Aids, 9, pp. 1079-1083.
3. Gao, F. and Korber, B. T. and Weaver, E. and Liao, H. X. and Hahn, B. H. and Haynes, B. F. (2004) Centralized immunogens as a vaccine strategy to overcome HIV-1 diversity. Expert Rev Vaccines, 3, pp. S161-S168.
4. Gaschen, B. and Taylor, J. and Yusim, K. and Foley, B. and Gao, F. and Lang, D. and Novitsky, V. and Haynes, B. and Hahn, B. H. and Bhattacharya, T. and Korber, B. (2002) Diversity considerations in HIV-1 vaccine selection. Science, 296, pp. 2354-2360.
5. ICASA Conference Report. (1999). In AIDS Vaccine for Africa. Lusaka, Zambia
6. Jenkins, R. A. and Temoshok, L. R. and Virochsiri, K. (1995) Incentives and disincentives to participate in prophylactic HIV vaccine research. Journal of Acquired Immune Deficiency Syndrome, 9, pp. 36-42.
7. Levine, C. (1991) Children in HIV/AIDS Trials: Still Vulnerable after All These Years. Law, Medicine and Health Care, 19, pp. 231-237.
8. Lindegger, G. and Richter, L. M. (2000) HIV vaccine trials: Critical issues in informed consent. South African Journal of Science, 96, pp. 313-317.
9. McGrath, J. W. and George, K. and Svilar, G. and Ihler, E. and Mafigiri, D. and Kabugo, M. and Mugisha, E. (2001a) Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndrome, 27, pp. 381-388.
10. McGrath, J. W. and Mafigiri, D. and Kamya, M. and George, K. and Senvewo, R. and Svilar, G. and Kabugo, M. and Mugisha, E. (2001b) Developing AIDS vaccine trials educational programs in Uganda. Journal of Acquired Immune Deficiency Syndrome, 26, pp. 176-181.
11. Mokili, J. and Korber, B. (2005) The spread of HIV in Africa. Journal of Neurovirology, 11 (Suppl. 1), pp. 66-75.
12. Mokili, J. L. and Rogers, M. and Carr, J. K. and Simmonds, P. and Bopopi, J. M. and Foley, B. T. and Korber, B. T. and Birx, D. L. and McCutchan, F. E. (2002) Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo. AIDS Research and Human Retroviruses, 18, pp. 817-823.
13. Mokili, J. L. and Wade, C. M. and Burns, S. M. and Cutting, W. A. and Bopopi, J. M. and Green, S. D. and Peutherer, J. F. and Simmonds, P. (1999) Genetic heterogeneity of HIV type 1 subtypes in Kimpese, rural Democratic Republic of Congo. AIDS Research and Human Retroviruses, 15, pp. 655-664.
14. Mulanga, C. and Bazepeo, S. E. and Mwamba, J. K. and Butel, C. and Tshimpaka, J. W. and Kashi, M. and Lepira, F. and Carael, M. and Peeters, M. and Delaporte, E. (2004) Political and socioeconomic instability: How does it affect HIV? A case study in the Democratic Republic of Congo. Aids, 18, pp. 832-834.
15. Nairobi-Declaration. (2000). In An African Appeal for an AIDS Vaccine. Nairobi: Nairobi-Declaration.
16. Vidal, N. and Mulanga, C. and Bazepeo, S. E. and Mwamba, J. K. and Tshimpaka, J. and Kashi, M. and Mama, N. and Valea, D. and Delaporte, E. and Lepira, F. and Peeters, M. (2006) HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC). AIDS Research and Human Retroviruses, 22, pp. 202-206.
17. WHO/CDC/PNLS. (2004). In Rapport du Passage de la Surveillance Sentinelle de VIH Chez les Femmes Enceintes Frequentant les Services de CPN Mai 2003 à mai 2004. Kinshasa: WHO/CDC/PNLS.
18. Yang, C. and Li, M. and Mokili, J. L. and Winter, J. and Lubaki, N. M. and Mwandagalirwa, K. M. and Kasali, M. J. and Losoma, A. J. and Quinn, T. C. and Bollinger, R. C. and Lal, R. B. (2005) Genetic diversification and recombination of HIV type 1 group M in Kinshasa, Democratic Republic of Congo. AIDS Research and Human Retroviruses, 21, pp. 661-666.